Outlook for 2017: Acute Leukemias, MDS, and CLL
This look ahead at hematologic malignancies in 2017 focuses on new agents being studied for the treatment of acute leukemias, myelodysplastic syndromes, and chronic lymphocytic leukemia.
Treatment of Acute Lymphoblastic Leukemia in Adults: Applying Lessons Learned in Children
In this article we discuss the challenges and new advances in adult ALL, as well as our approach to the treatment of these patients.
Acute Myeloid Leukemia: Biologic, Prognostic, and Therapeutic Insights
We review here the state of the art of diagnosis and treatment of AML and provide insights into the emerging novel biomarkers and therapeutic agents that are anticipated to be useful for the implementation of personalized medicine in AML.
2 Commerce Drive Cranbury, NJ 08512